Besides the role of PARP1, TNKS1–2poly-ARTs are currentlybeing investigated as potential therapeutic targets in cancer mainlydue to their role in controlling the Wnt/β-catenin signalingpathway. The gene discussed is PARP1; the disease is cancer.